MedPath

Tear Dynamics After Restasis Treatment in Dry Eye Patients

Completed
Conditions
Dry Eye
Registration Number
NCT00706940
Lead Sponsor
University of Miami
Brief Summary

Observe the changes of tear volume in dry eye patients after Restasis treatment of 3 months and during 6-month follow-up after discontinuation of study treatment.

Detailed Description

Using an imaging device name optical coherence tomography to image the tear volume in dry eye patients before and after Restasis treatment.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria

The participant will be eligible for entry in the study if s/he:

  1. Is at least 18 years old and has full legal capacity to volunteer;
  2. Has read and signed the IRB Informed Consent Document;
  3. Is willing and able to follow participant instructions;
  4. Has clear corneas;
  5. Has 20/100 uncorrected visual acuity or better;
  6. Has dry eye according to the study definition of DES (study subjects);
  7. Has not use Restasis within 3 months.
Exclusion Criteria

The subjects will ineligible for entry into the study if s/he:

  1. Has any systemic disease affecting ocular health except for Sjögren's syndrome;
  2. Is using any systemic or topical medications that will affect ocular health except for artificial tears;
  3. Has an active ocular disease other than DES, or Sjögren's syndrome
  4. Has any clinically significant lid or conjunctival abnormalities, neovascularization, corneal scars or corneal opacities;
  5. Has limbal or bulbar injection or corneal staining that was clinically significant, which are not due to DES;
  6. Has worn rigid gas permeable lenses within 1 year and during the study;
  7. Has had surgery or an eye injury within 6 months;
  8. Was a soft contact lens wearer within 2 weeks and during the study.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Tear meniscus volume after treatment3 months

Significant increase in tear meniscus volume was found in patients after 3 months of treatment.

Increase in tear volume after the 3-month treatment and returned to baseline during 6-month follow-up after discontinuation of study treatment.3 months for treatment and follow-up of 6 months after discontinuation of study treatment.
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Bascom Palmer Eye Institute

🇺🇸

Miami, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath